CoChat
Sign Up
Cited by 197

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake

Zhao, Xiaoyin, Wu, Dongliang, Ma, Xudong, Wang, Jiale, Hou, Wenjun, Zhang, Wen·2020·Biomedicine & Pharmacotherapy
DOI 10.1016/j.biopha.2020.110237
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.110237

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 18 references

Research works printed but not linked: 84

  1. Wolfers, 2001, Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat. Med., 7, 297, 10.1038/85438 · DOI
  2. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  3. S.E. Flaherty, A. Grijalva, X. Xu, E. Ables, A. Nomani, A.W.J.S. Ferrante, A lipase-independent pathway of lipid release and immune modulation by adipocytes, 363(6430) 989-993. · DOI
  4. Ibrahim, 2019, Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories, Nat. Biomed. Eng., 3, 695, 10.1038/s41551-019-0448-6 · DOI
  5. Poggio, 2019, Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory, Cell, 177, 10.1016/j.cell.2019.02.016 · DOI · Paper page
  6. Vlassov, 2012, Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, Biochim. Biophys. Acta, 1820, 940, 10.1016/j.bbagen.2012.03.017 · DOI
  7. Tkach, 2016, Communication by extracellular vesicles: where we are and where we need to go, Cell, 164, 1226, 10.1016/j.cell.2016.01.043 · DOI · Paper page
  8. Kim, 2018, Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations, Nanomedicine, 14, 195, 10.1016/j.nano.2017.09.011 · DOI · Paper page
  9. Wan, 2018, Aptamer-conjugated extracellular nanovesicles for targeted drug delivery, Cancer Res., 78, 798, 10.1158/0008-5472.CAN-17-2880 · DOI
  10. Kooijmans, 2012, Exosome mimetics: a novel class of drug delivery systems, Int. J. Nanomedicine, 7, 1525
  11. van Dommelen, 2012, Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery, J. Control. Release, 161, 635, 10.1016/j.jconrel.2011.11.021 · DOI
  12. Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 · DOI · Paper page
  13. Thery, 2002, Exosomes: composition, biogenesis and function, Nat. Rev. Immunol., 2, 569, 10.1038/nri855 · DOI
  14. Hurley, 2010, Membrane budding and scission by the ESCRT machinery: it’s all in the neck, Nat. Rev. Mol. Cell Biol., 11, 556, 10.1038/nrm2937 · DOI
  15. Luzio, 2010, Endosome-lysosome fusion, Biochem. Soc. Trans., 38, 1413, 10.1042/BST0381413 · DOI
  16. Thery, 2011, Exosomes: secreted vesicles and intercellular communications, F1000 Biol. Rep., 3, 15, 10.3410/B3-15 · DOI · Paper page
  17. Bebelman, 2018, Biogenesis and function of extracellular vesicles in cancer, Pharmacol. Ther., 10.1016/j.pharmthera.2018.02.013 · DOI
  18. Ciardiello, 2016, Focus on extracellular vesicles: new frontiers of cell-to-Cell communication in Cancer, Int. J. Mol. Sci., 17, 10.3390/ijms17020175 · DOI
  19. Rahbarghazi, 2019, Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications, Cell Commun. Signal, 17, 73, 10.1186/s12964-019-0390-y · DOI
  20. Willms, 2018, Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in Cancer progression, Front. Immunol., 9, 738, 10.3389/fimmu.2018.00738 · DOI
  21. Peinado, 2012, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET, Nat. Med., 18, 883, 10.1038/nm.2753 · DOI · Paper page
  22. Yong, 2020, Extracellular vesicles for tumor targeting delivery based on five features principle, J. Control. Release, 322, 555, 10.1016/j.jconrel.2020.03.039 · DOI
  23. Rani, 2015, Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications, Mol. Ther., 23, 812, 10.1038/mt.2015.44 · DOI
  24. Vader, 2016, Extracellular vesicles for drug delivery, Adv. Drug Deliv. Rev., 106, 148, 10.1016/j.addr.2016.02.006 · DOI · Paper page
  25. De Jong, 2014, Extracellular vesicles: potential roles in regenerative medicine, Front. Immunol., 5, 608, 10.3389/fimmu.2014.00608 · DOI
  26. Gyorgy, 2017, Rescue of hearing by gene delivery to inner-ear hair cells using exosome-associated AAV, Mol. Ther., 25, 379, 10.1016/j.ymthe.2016.12.010 · DOI · Paper page
  27. Robbins, 2016, Regulation of chronic inflammatory and immune processes by extracellular vesicles, J. Clin. Invest., 126, 1173, 10.1172/JCI81131 · DOI
  28. Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 · DOI · Paper page
  29. Katakowski, 2013, Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth, Cancer Lett., 335, 201, 10.1016/j.canlet.2013.02.019 · DOI · Paper page
  30. Wang, 2017, Exosome - miR-335 as a novel therapeutic strategy in hepatocellular carcinoma, Hepatology
  31. Ding, 2019, Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression, Cancer Lett., 442, 351, 10.1016/j.canlet.2018.10.039 · DOI · Paper page
  32. Zeng, 2018, Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis, Nat. Commun., 9, 5395, 10.1038/s41467-018-07810-w · DOI
  33. Usman, 2018, Efficient RNA drug delivery using red blood cell extracellular vesicles, Nat. Commun., 9, 2359, 10.1038/s41467-018-04791-8 · DOI · Paper page
  34. Mao, 2018, Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis, Cancer Gene Ther., 25, 248, 10.1038/s41417-018-0032-3 · DOI
  35. Shokrollahi, 2019, Treatment of human neuroblastoma cell line SH-SY5Y with HSP27 siRNA tagged-exosomes decreased differentiation rate into mature neurons, J. Cell. Physiol., 234, 21005, 10.1002/jcp.28704 · DOI
  36. Hartman, 2011, Increasing vaccine potency through exosome antigen targeting, Vaccine, 29, 9361, 10.1016/j.vaccine.2011.09.133 · DOI · Paper page
  37. Andre, 2004, Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells, J. Immunol., 172, 2126, 10.4049/jimmunol.172.4.2126 · DOI · Paper page
  38. Romagnoli, 2014, Dendritic cell-derived exosomes may be a tool for Cancer immunotherapy by converting tumor cells into immunogenic targets, Front. Immunol., 5, 692
  39. Xie, 2010, Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8+ CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70, J. Cell. Mol. Med., 14, 2655, 10.1111/j.1582-4934.2009.00851.x · DOI
  40. Rivoltini, 2016, TNF-related apoptosis-inducing ligand (TRAIL)-Armed exosomes deliver proapoptotic signals to tumor site, Clin. Cancer Res., 22, 3499, 10.1158/1078-0432.CCR-15-2170 · DOI · Paper page
  41. Kooijmans, 2016, Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting, J. Extracell. Vesicles, 5, 31053, 10.3402/jev.v5.31053 · DOI
  42. Kim, 2017, Exosome-SIRP alpha, a CD47 blockade increases cancer cell phagocytosis, Biomaterials
  43. Mulcahy, 2014, Routes and mechanisms of extracellular vesicle uptake, J. Extracell. Vesicles, 3, 10.3402/jev.v3.24641 · DOI · Paper page
  44. Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
  45. Kim, 2015, Development of exosome-encapsulated paclitaxel to overcome MDR in Cancer cells, Nanomedicine
  46. Saari, 2015, Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells, J. Control. Release, 10.1016/j.jconrel.2015.09.031 · DOI · Paper page
  47. Osterman, 2015, curcumin modulates pancreatic adenocarcinoma cell-derived exosomal function, PLoS One, 10, 10.1371/journal.pone.0132845 · DOI
  48. Mendt, 2018, Generation and testing of clinical-grade exosomes for pancreatic cancer, JCI Insight, 3, 10.1172/jci.insight.99263 · DOI
  49. Haney, 2015, Exosomes as drug delivery vehicles for Parkinson’s disease therapy, J. Control. Release, 10.1016/j.jconrel.2015.03.033 · DOI · Paper page
  50. Bryniarski, 2013, Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity, J. Allergy Clin. Immunol., 132, 170, 10.1016/j.jaci.2013.04.048 · DOI
  51. Wang, 2017, Cell-derived exosomes as promising carriers for drug delivery and targeted therapy, Curr. Cancer Drug Targets
  52. Moore, 2017, The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy, Int. J. Cancer, 10.1002/ijc.30672 · DOI
  53. Lv, 2012, Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro, J. Biol. Chem., 287, 15874, 10.1074/jbc.M112.340588 · DOI · Paper page
  54. Pascucci, 2014, Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery, J. Control. Release, 10.1016/j.jconrel.2014.07.042 · DOI · Paper page
  55. Behzadi, 2017, Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor, Microb. Pathog., 111, 132, 10.1016/j.micpath.2017.08.027 · DOI
  56. Lee, 2015, Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration, Nano Lett., 15, 2938, 10.1021/nl5047494 · DOI
  57. Sterzenbach, 2017, Engineered exosomes as vehicles for biologically active proteins, Mol. Ther., 10.1016/j.ymthe.2017.03.030 · DOI
  58. Lin, 2018, Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs, Adv. Sci. Weinh. (Weinh), 5
  59. Raposo, 1996, B lymphocytes secrete antigen-presenting vesicles, J. Exp. Med., 183, 1161, 10.1084/jem.183.3.1161 · DOI · Paper page
  60. Tkach, 2017, Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes, EMBO J., 10.15252/embj.201696003 · DOI
  61. Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 · DOI · Paper page
  62. Mack, 2000, Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection, Nat. Med., 6, 769, 10.1038/77498 · DOI
  63. Korkut, 2013, Regulation of postsynaptic retrograde signaling by presynaptic exosome release, Neuron, 77, 1039, 10.1016/j.neuron.2013.01.013 · DOI · Paper page
  64. Chivet, 2014, Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons, J. Extracell. Vesicles, 3, 24722, 10.3402/jev.v3.24722 · DOI · Paper page
  65. Horibe, 2018, Mechanism of recipient cell-dependent differences in exosome uptake, BMC Cancer, 18, 10.1186/s12885-017-3958-1 · DOI
  66. Christianson, 2013, Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity, Proc Natl Acad Sci U S A, 110, 17380, 10.1073/pnas.1304266110 · DOI · Paper page
  67. Costa Verdera, 2017, Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis, J. Control. Release, 266, 100, 10.1016/j.jconrel.2017.09.019 · DOI
  68. Doherty, 2009, Mechanisms of endocytosis, Annu. Rev. Biochem., 78, 857, 10.1146/annurev.biochem.78.081307.110540 · DOI · Paper page
  69. Svensson, 2013, Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1, J. Biol. Chem., 288, 17713, 10.1074/jbc.M112.445403 · DOI
  70. Nanbo, 2013, Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells, J. Virol., 87, 10334, 10.1128/JVI.01310-13 · DOI
  71. Lai, 2014, Nonaggregated alpha-synuclein influences SNARE-dependent vesicle docking via membrane binding, Biochemistry, 53, 3889, 10.1021/bi5002536 · DOI
  72. Kanada, 2015, Differential fates of biomolecules delivered to target cells via extracellular vesicles, Proc. Natl. Acad. Sci. U.S.A, 10.1073/pnas.1418401112 · DOI
  73. Santos, 2018, VAMP-associated protein-A and oxysterol-binding protein-related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum, J. Biol. Chem., 293, 13834, 10.1074/jbc.RA118.003725 · DOI
  74. Heusermann, 2016, Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER, J. Cell Biol., 213, 173, 10.1083/jcb.201506084 · DOI · Paper page
  75. Parolini, 2009, Microenvironmental pH is a key factor for exosome traffic in tumor cells, J. Biol. Chem., 284, 34211, 10.1074/jbc.M109.041152 · DOI
  76. Saari, 2018, FLIM reveals alternative EV-mediated cellular up-take pathways of paclitaxel, J. Control. Release, 284, 133, 10.1016/j.jconrel.2018.06.015 · DOI
  77. Hille, 2008, Time-domain fluorescence lifetime imaging for intracellular pH sensing in living tissues, Anal. Bioanal. Chem., 391, 1871, 10.1007/s00216-008-2147-0 · DOI
  78. Dziuba, 2016, A rotational BODIPY nucleotide: an environment-sensitive fluorescence-lifetime probe for DNA interactions and applications in Live-Cell microscopy, Angew. Chem. Int. Ed. Engl., 55, 174, 10.1002/anie.201507922 · DOI
  79. El Andaloussi, 2013, Exosomes for targeted siRNA delivery across biological barriers, Adv. Drug Deliv. Rev., 65, 391, 10.1016/j.addr.2012.08.008 · DOI
  80. Yeo, 2013, Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery, Adv. Drug Deliv. Rev., 65, 336, 10.1016/j.addr.2012.07.001 · DOI · Paper page
  81. Andriolo, 2018, Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-Grade manufacturing method, Front. Physiol., 9, 1169, 10.3389/fphys.2018.01169 · DOI
  82. Yang, 2020, Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics, Theranostics, 10, 3684, 10.7150/thno.41580 · DOI
  83. Maroto, 2017, Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses, J. Extracell. Vesicles, 6, 10.1080/20013078.2017.1359478 · DOI · Paper page
  84. Sarker, 2014, Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy, J. Transl. Med., 12, 204, 10.1186/1479-5876-12-204 · DOI

Cited by

Sorted by citations

See all 197

Metadata

Authors
Zhao, X., Wu, D., Ma, X., Wang, J., Hou, W., & Zhang, W.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2020-08
Volume
128
Pages
110237
ISSN
0753-3322
DOI
10.1016/j.biopha.2020.110237
Cited by
197
References
18
Language
en
Licence
Funders
  • National Natural Science Foundation of China (31500739)
  • Natural Science Foundation of Zhejiang Province (LY18B020020)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review